cdmo.directory
← Compare landing

CMC Pharmaceuticals, Inc. vs Dipharma

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryCMC Pharmaceuticals, Inc.Dipharma
SummaryCMC Pharma provides integrated formulation development, analytical testing, stability studies, and cGMP manufacturing oversight for small molecule drug programs from preclinical through post-approval, with hands-on regulatory expertise and CMO management built in.Global CDMO and API manufacturer with 600 employees, 4 cGMP plants, and 75+ years of experience in hazardous chemical synthesis, offering exclusive synthesis services and catalogue APIs with FDA, AIFA, and PMDA inspections since 1970.
Services
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • Controlled Substance Manufacturing
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • CMC Regulatory Submission Support
  • API Synthesis & Manufacturing
  • Process Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • CMC Regulatory Submission Support
Modalities
  • Small Molecule
  • Small Molecule
Development capabilities
  • Analytical method development
  • Formulation development
  • ICH stability testing
  • Analytical method development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • HPAPI
  • DEA licensed
  • Drug Substance (DS)
  • Drug Product (DP)
Locations
  • Headquarters, Solon, Ohio, United States
  • Headquarters, Milan, Lombardy, Italy
  • Commercial Office, United States
  • Commercial Office, China
CertificationsData not yet provided.Data not yet provided.

Find similar companies

CMC Pharmaceuticals, Inc. alternatives · Dipharma alternatives

Markdown mirror: /compare/cmcpharm/dipharma.md